MedPath

Shanghai Cell Therapy Research Institute

πŸ‡¨πŸ‡³China
Ownership
Private
Established
2014-08-27
Employees
-
Market Cap
-
Website
http://www.shcell.org/

Clinical Trials

4

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
4 (100.0%)

PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor

Phase 1
Conditions
Advanced Solid Tumor
First Posted Date
2018-08-03
Last Posted Date
2018-08-03
Lead Sponsor
Shanghai Cell Therapy Research Institute
Target Recruit Count
50
Registration Number
NCT03615313
Locations
πŸ‡¨πŸ‡³

China, Shanghai, Shanghai, China

CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor

Phase 1
Conditions
Advanced Solid Tumor
First Posted Date
2017-06-09
Last Posted Date
2017-06-09
Lead Sponsor
Shanghai Cell Therapy Research Institute
Target Recruit Count
40
Registration Number
NCT03182803
Locations
πŸ‡¨πŸ‡³

Ningbo No.5 Hospital (Ningbo Cancer Hospital), Ningbo, Zhejiang, China

CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor

Phase 1
Conditions
Advanced Solid Tumor
First Posted Date
2017-06-09
Last Posted Date
2017-06-09
Lead Sponsor
Shanghai Cell Therapy Research Institute
Target Recruit Count
40
Registration Number
NCT03182816
Locations
πŸ‡¨πŸ‡³

Ningbo No.5 Hospital (Ningbo Cancer Hospital), Ningbo, Zhejiang, China

CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor

Phase 1
Conditions
Advanced Solid Tumor
First Posted Date
2017-06-07
Last Posted Date
2017-06-07
Lead Sponsor
Shanghai Cell Therapy Research Institute
Target Recruit Count
40
Registration Number
NCT03179007
Locations
πŸ‡¨πŸ‡³

Ningbo No.5 Hospital (Ningbo Cancer Hospital), Ningbo, Zhejiang, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.